Globally, COVID caseload has topped 183.4 million, while the deaths have surged to more than 3.96 million, according to the Johns Hopkins University.
COVID-19 Vaccination in India: Issues and Challenges
India’s COVID-19 vaccination program has been launched. It currently uses the vaccines Covishield and Covaxin. There are some issues and challenges that need to be overcome in order to vaccinate all Indians.
India’s COVID-19 vaccination program has been launched. It currently uses the vaccines Covishield and Covaxin. There are some issues and challenges that need to be overcome in order to vaccinate all Indians.
‘The US continues to be the worst-hit country with the world's highest number of COVID-19 cases and deaths at 33,713,729 and 605,493, respectively.’
In terms of infections, India follows in the second place with 30,502,362 cases. The other worst countries with over 3 million cases are Brazil (18,742,025), France (5,845,622), Russia (5,519,516), Turkey (5,440,368), the UK (4,896,272), Argentina (4,526,473), Colombia (4,324,230), Italy (4,262,511), Spain (3,833,868), Germany (3,738,059) and Iran (3,241,037), the CSSE figures showed.
In terms of deaths, Brazil comes second with 523,587 fatalities.
Risk Factors for Severe COVID-19 in Individuals With Sickle Cell Disease Identified
In individuals with sickle cell disease (SCD) a history of severe pain episodes and coexisting organ conditions, increase the risk of severe COVID-19 illness.
In individuals with sickle cell disease (SCD) a history of severe pain episodes and coexisting organ conditions, increase the risk of severe COVID-19 illness.
Source-IANS
Role of T Cells in Fight Against COVID-19 Variants
T cell response through COVID-19 vaccines makes the immune system to recognize these new variants and stop severe COVID-19 infection.
T cell response through COVID-19 vaccines makes the immune system to recognize these new variants and stop severe COVID-19 infection.
World's First Plasmid DNA Covid Vax: Zydus Cadila Seeks Approval of DCGI
Zydus Cadila, a pharma company has applied for emergency use authorization (EUA) for ZyCoV-D. It will be the world's first DNA vaccine against Covid-19. Both adults and adolescents can take the vaccine, when approved by the Drugs Controller General of India (DCGI).
Zydus Cadila, a pharma company has applied for emergency use authorization (EUA) for ZyCoV-D. It will be the world's first DNA vaccine against Covid-19. Both adults and adolescents can take the vaccine, when approved by the Drugs Controller General of India (DCGI).
